Metformin Hydrochloride Sustained Release Tablets IP 500 Mg – DEBAMET 500 SR

Metformin Hydrochloride Sustained Release Tablets IP 500 Mg -Sustained efficacy, improved tolerability, and trusted management for T2DM and beyond.

DEBAMET 500 SR – The composition of Metformin 500 mg SR is an oral biguanide antidiabetic that works primarily by reducing hepatic glucose production, enhancing peripheral glucose uptake, and improving insulin sensitivity. Its sustained-release formulation ensures gradual absorption, reducing peak plasma levels and minimizing gastrointestinal discomfort. It is widely used as a cornerstone therapy for type 2 diabetes and is beneficial in managing metabolic syndrome and insulin resistance.

Recommended BY Specialists:
Endocrinologists: It is mainly used to prefer this combination to treat the disease associated with the primary drug of choice for newly diagnosed Type 2 diabetes patients
General Physicians: It is used to prefer this combination mainly for long-term glycemic control and a weight-neutral effect
Gynecologists: It is often prescribed for the treatment of diseases associated with PCOS to improve insulin resistance, ovulation, and menstrual regularity

Key Benefits of Metformin Hydrochloride Sustained Release Tablets IP 500 Mg – DEBAMET 500 SR
Sustained Release for Better Tolerability: Slow and steady release of metformin ensures fewer gastrointestinal side effects like nausea and bloating, improving patient adherence.
First-Line Therapy for Type 2 Diabetes: Proven efficacy in glycemic control, weight neutrality, and insulin sensitivity improvement makes it a gold-standard treatment.
Cardiovascular and Metabolic Benefits: Reduces HbA1c levels, supports weight management, and offers potential cardiovascular protective effects.

INDICATIONS:
Type 2 Diabetes Mellitus
Pre-diabetes Management
Polycystic Ovary Syndrome (PCOS)
Metabolic Syndrome